Investors are often on the lookout for CBD plays nowadays owing to the potential growth in the sector and one of the companies that you could look into today is CBD Life Sciences (OTCMKTS:CBDL).
CBD Life Sciences, Inc. (CBDL) Launches Premium Terpene Infused Oil
Yesterday, the company’s fully owned subsidiary unit LBC Bioscience Inc announced that it has been successful in developing a new CBD Oil, which had been laced with premium terpenes. It was further noted that the product was going to be made available on the LBC Bioscience website in the next few days. It was a major new announcement from the company and it now remains to be seen if the CBD Life Sciences stock gets any attention from investors or not over the coming days.
Not too long ago LBC Bioscience had built its own manufacturing plant for developing new products. One of the products that it had managed to develop was the Premium Non-GMO Tincture and it had been made available in strengths of 500 MG, 1500 MG and 3000 MG variants. In addition to that, the tincture described above is also going to be made available in as many as 14 distinct flavours and will be laced with premium terpenes.
 Stock On Radar: Company Launches Premium Terpene Infused Oil){kind=link}